Terms of Use

Onyx Pharmaceuticals, Inc. (“Onyx” or the “Company”) website has been designed to provide general information about Onyx. Through your access to and use of this web site, you accept, without limitation or qualification, the terms and conditions set forth below. Please review the following terms and conditions concerning your use of Onyx’s web site. By accessing and using any information and/or materials from this website, you agree to be bound by these terms and conditions. Onyx reserves the right to change these terms and conditions from time to time. If you do not agree with these terms and conditions, do not use this website. In the case of any violation of these terms and conditions, Onyx reserves the right to seek all remedies available by law and in equity for such violations. These terms and conditions apply to all visits to our web site.


This website is not intended to be used in making any decision relating to an investment in the securities of Onyx. Investors and prospective investors are urged to review and consider thoroughly the materials that the Company files with the Securities and Exchange Commission, or the SEC. All information contained on this website is qualified in its entirety by reference to those SEC filings.

Although Onyx has attempted to provide accurate information on this website, the Company assumes no responsibility for the accuracy of the information. The continued accuracy of this information cannot be assured. Information and materials contained on this website may be out of date or include omissions or other errors. Onyx may change the information provided on this website at any time without notice. All information provided on this web site is provided “AS IS” without warranty of any kind.

The information available on this website is not intended to provide medical advice. Patients are urged to consult with their treating physicians.

Certain links on this website lead to resources maintained by others over whom Onyx has no control. As such, Onyx does not adopt, endorse, support or make any representation as to the truth, accuracy, completeness, legality of any other aspect of the information contained in those resources.

Forward-looking Statements

This website contains forward-looking statements. Any statements contained in this web site that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “anticipates”, “believes”, “estimates”, “expects”, “intends”, “may”, “plans”, “should”, “will” and similar expressions are intended to identify forward-looking statements. Actual events may differ from the Company’s expectations. In addition to the matters described on this website, the following may affect the actual results achieved by the Company: the Company’s early stage of development; the timeline for clinical activity; the results of pending or future clinical trials; the lack of assurance of regulatory approvals; changes in the status of the Company’s collaborative relationships; competition; the risks associated with the issuance of patents and the protection therefrom; and general economic conditions as well as the information appearing under the caption “Risk Factors” listed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission, including but not limited to its Annual Report on Form 10-K (see “Investor Relations: SEC Filings” page of this website).

Trademarks and Copyrights

This Site and the Materials herein are copyrighted works of Onyx and may not be reproduced, displayed, modified or adapted, distributed or transmitted in any form by any means without the prior written permission of Onyx, except as set forth in these terms of use. Onyx, Onyx Pharmaceuticals, the Onyx Logo, and Changing The Way Cancer Is Treated are trademarks of Onyx Pharmaceuticals, Inc. Nexavar® is a registered trademark of Bayer Pharmaceuticals Corporation which is licensed to Onyx. All rights reserved. All other trademarks are the property of their respective owners.

Stock Quote (update every 15 minutes): As of 4:00pm - 5/20/2011

  • Symbol
  • Last
    43.71 +0.22
  • Open
  • High
  • Low
  • Volume